These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 6929409

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Comparison of cepharadine and cephalexin in the treatment of respiratory and urinary tract infections.
    Mogabgab WJ.
    Curr Ther Res Clin Exp; 1976 Apr; 19(4):421-32. PubMed ID: 4284
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. A new cephalosporin derivative, cephradine (TM) , in the treatment of acute infective diseases.
    Limson BM, Siasoco RE, Dial FP.
    Curr Ther Res Clin Exp; 1972 Mar; 14(3):101-6. PubMed ID: 4622888
    [No Abstract] [Full Text] [Related]

  • 26. Comparison of cephradine and cephalothin in the treatment of urinary tract infections.
    Caloza DL, Losi MJ, Fields LA.
    N C Med J; 1977 Oct; 38(10):597-600. PubMed ID: 335255
    [No Abstract] [Full Text] [Related]

  • 27. Results of Poteseptyl treatment in enteric, otic and urinary tract infections.
    Vâta A, Dimitriu S, Turcu T.
    Ther Hung; 1977 Oct; 25(2):79-81. PubMed ID: 898121
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Use of a new cephalosporin in pediatrics].
    Radice C.
    Minerva Pediatr; 1977 Jun 16; 29(21):1379-83. PubMed ID: 882081
    [No Abstract] [Full Text] [Related]

  • 30. [Treatment with cephalexin monohydrate of urinary tract infections in children. Preliminary report].
    De La Torre JA, Filloy L, Mendez Tena E, Olarte J, Torregrosa L.
    Prensa Med Mex; 1970 Jun 16; ():87-91. PubMed ID: 4931124
    [No Abstract] [Full Text] [Related]

  • 31. The use of antibiotics in paediatrics.
    Illingworth RS.
    J Coll Gen Pract; 1965 Nov 16; 10 Suppl 1():Suppl 1:9-15. PubMed ID: 4378717
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Laboratory and clinical evaluation of cephradine for injection (author's transl)].
    Nakagawa K, Watanabe K, Kabe J, Suzuki T.
    Jpn J Antibiot; 1976 Nov 16; 29(11):985-90. PubMed ID: 1003683
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Cefdinir pharmacokinetics and tolerability in children receiving 25 mg/kg once daily.
    Bowlware KL, McCracken GH, Lozano-Hernandez J, Ghaffar F.
    Pediatr Infect Dis J; 2006 Mar 16; 25(3):208-10. PubMed ID: 16511381
    [Abstract] [Full Text] [Related]

  • 37. [Pannodine in treatment of selected acute infections in children].
    Pinkawa E, Surowiec A.
    Wiad Lek; 1974 Mar 01; 27(5):467-8. PubMed ID: 4849339
    [No Abstract] [Full Text] [Related]

  • 38. [Pannodine in treatment of selected acute infections in children].
    Pinkawa E, Surowiec A.
    World Health Organ Tech Rep Ser; 1974 Mar 01; 27(5):467-8. PubMed ID: 4206991
    [No Abstract] [Full Text] [Related]

  • 39. [B.I.D. administration of cephradin in the treatment of cystitis and pyelonephritis (author's transl)].
    Ruiloba J, Palacios GR.
    Rev Invest Clin; 1977 Mar 01; 29(2):137-41. PubMed ID: 331425
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.